CIK 0001862150 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -22.4 M | -23.5 M | -17.7 M |
| Diluted EPS (USD/shares) | -4.44 | -311.99 | -29.35 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 4 | 4 | 2026-09-30 |
| 2026-10-02 | 8-K | 8-K items 5.02,9.01 | 2026-09-30 |
| 2026-08-13 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-13 | 8-K | 8-K items 2.02,9.01 | 2026-08-13 |
| 2026-07-23 | 8-K | 8-K items 5.02 | 2026-07-17 |
| 2026-07-20 | 4 | 4 | 2026-07-16 |
| 2026-07-20 | 4 | 4 | 2026-07-16 |
| 2026-07-20 | 4 | 4 | 2026-07-16 |
| 2026-07-20 | 4 | 4 | 2026-07-16 |
| 2026-07-20 | 4 | 4 | 2026-07-16 |
| 2026-07-20 | 4 | 4 | 2026-07-16 |
| 2026-07-20 | 4 | 4 | 2026-07-16 |
| 2026-07-20 | 4 | 4 | 2026-07-16 |
| 2026-07-15 | S-8 | S-8 | |
| 2026-07-14 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-07-09 |
| 2026-07-02 | 4 | 4 | 2026-06-30 |
| 2026-07-02 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-06-30 |
| 2026-06-16 | 8-K | 8-K items 7.01,9.01 | 2026-06-16 |
| 2026-06-08 | 4 | 4 | 2026-02-13 |
| 2026-06-08 | 3 | 3 | 2026-02-13 |
| 2026-06-02 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-06-02 |
| 2026-05-29 | DEF 14A | DEF 14A | 2026-05-29 |
| 2026-05-29 | ARS | ARS | 2025-12-31 |
| 2026-05-29 | DEFA14A | DEFA14A | |
| 2026-05-19 | 8-K | 8-K items 5.02 | 2026-05-18 |
Forms on file (last 1,000): 4 152, 8-K 99, CORRESP 26, 3 23, SC 13D/A 21, EFFECT 16, UPLOAD 16, 10-Q 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CING (0.002 USD), /gw/filings/filings?ticker=CING&form=8-K, /gw/filings/facts?ticker=CING&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange